Trial Profile
A phase-I, open-label study evaluating the pharmacokinetics of quizartinib in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Nov 2017
Price :
$35
*
At a glance
- Drugs Quizartinib (Primary)
- Indications Acute myeloid leukaemia
- Focus Pharmacokinetics
- 01 Nov 2017 New trial record
- 01 Oct 2017 Results published in the Xenobiotica